Neurotech CEO Rich Small on ENCELTO™ and Redefining Retinal Cell-Based Gene Therapy | Eyecelerator 2025
At Eyecelerator 2025, Neurotech CEO Rich Small shares the story behind ENCELTO™, a first-in-class encapsulated cell-based gene therapy for the…
Inside Eyecelerator: What’s It All About?
Ever wondered what actually goes down at Eyecelerator? In this exclusive MICE TV video, we’re backstage at Eyecelerator 2025—held alongside…
latest posts
